Blood | American Society of Hematology

Skip Nav Destination

Current Issue

Volume 145,

Issue 3,

January 16 2025

View This Issue

Issue Highlights

IFN-I promotes T-cell–independent immunity and RBC autoantibodies in murine SCD
CME article: brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced stage HL
Daratumumab/lenalidomide vs lenalidomide as posttransplant maintenance in MM
Genetic alteration of class I HLA in cutaneous T-cell lymphoma
Progression risk of MGUS by method of detection
Review: current MPN scoring systems for clinical practice
How I Treat: older patients with R/R DLBCL

Latest in Blood

Free Articles

Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations

Oscar Silva; Allison Shaw

https://doi.org/10.1182/blood.2021012538

View All Free Articles

Plenary Papers

Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study

Ada Antypiuk; S. Zebulon Vance; Richa Sharma; Sara Passos; Michela Asperti; Shobana Navaneethabalakrishan; Franz Dürrenberger; Vania Manolova; Francesca Vinchi

https://doi.org/10.1182/blood.2024026135

View All Plenary Papers

First Edition

Defining 2 Biologically and Clinically Distinct Groups in Acute Leukemia with a Mixed Phenotype

Pallavi Galera; Deepika Dilip; Andriy Derkach; Alexander Chan; Yanming Zhang; Sonali Persaud; Tanmay Mishra; Kyle Kramer; Mahak Kathpalia; Ying Liu; Christopher A Famulare; Qi Gao; Douglas Alexander Mata; Maria E. Arcila; Mark B. Geyer; Eytan M. Stein; Ahmet Dogan; Mikhail Roshal; Ross L Levine; Jacob L. Glass; Wenbin Xiao

https://doi.org/10.1182/blood.2024026273

View All First Edition Articles

Clinical Trials and Observations

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

Ashraf Badros; Laahn Foster; Larry D. Anderson, Jr; Chakra P. Chaulagain; Erin Pettijohn; Andrew J. Cowan; Caitlin Costello; Sarah Larson; Douglas W. Sborov; Kenneth H. Shain; Rebecca Silbermann; Nina Shah; Alfred Chung; Maria Krevvata; Huiling Pei; Sharmila Patel; Vipin Khare; Annelore Cortoos; Robin Carson; Thomas S. Lin; Peter Voorhees

https://doi.org/10.1182/blood.2024025746

View All Clinical Trials and Observations

Advertisement intended for health care professionals

170,000 citations
earned in 2023

Vote for your favorite 2024 Blood Cover
Year in review: Blood's ten most read articles published in 2024
Acknowledgement of Reviewers

Featured Content

Brentuximab vedotin, nivolumab, and chemotherapy in classical Hodgkin lymphoma; type 1 interferon signaling in sickle cell disease; and type 1 human leukocyte antigen gene mutations in cutaneous T-cell lymphoma

Issue Highlights

170,000 citations
earned in 2023

Featured Content

Brentuximab vedotin, nivolumab, and chemotherapy in classical Hodgkin lymphoma; type 1 interferon signaling in sickle cell disease; and type 1 human leukocyte antigen gene mutations in cutaneous T-cell lymphoma

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma

IFN-I promotes T-cell–independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD

Genetic alteration of class I HLA in cutaneous T-cell lymphoma

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection

ASH Publications

American Society of Hematology

Issue Highlights

170,000 citations earned in 2023

Featured Content

Brentuximab vedotin, nivolumab, and chemotherapy in classical Hodgkin lymphoma; type 1 interferon signaling in sickle cell disease; and type 1 human leukocyte antigen gene mutations in cutaneous T-cell lymphoma

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma

IFN-I promotes T-cell–independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD

Genetic alteration of class I HLA in cutaneous T-cell lymphoma

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

170,000 citations
earned in 2023